NRS 689A.0415
Coverage for hormone replacement therapy in certain circumstances

  • prohibited actions by insurer
  • exception.

1.

An insurer that offers or issues a policy of health insurance which provides coverage for prescription drugs or devices shall include in the policy coverage for any type of hormone replacement therapy which is lawfully prescribed or ordered and which has been approved by the Food and Drug Administration.

2.

An insurer that offers or issues a policy of health insurance that provides coverage for prescription drugs shall not:

(a)

Require an insured to pay a higher deductible, any copayment or coinsurance or require a longer waiting period or other condition for coverage for a prescription for hormone replacement therapy;

(b)

Refuse to issue a policy of health insurance or cancel a policy of health insurance solely because the person applying for or covered by the policy uses or may use in the future hormone replacement therapy;

(c)

Offer or pay any type of material inducement or financial incentive to an insured to discourage the insured from accessing hormone replacement therapy;

(d)

Penalize a provider of health care who provides hormone replacement therapy to an insured, including, without limitation, reducing the reimbursement of the provider of health care; or

(e)

Offer or pay any type of material inducement, bonus or other financial incentive to a provider of health care to deny, reduce, withhold, limit or delay hormone replacement therapy to an insured.

3.

A policy subject to the provisions of this chapter that is delivered, issued for delivery or renewed on or after October 1, 1999, has the legal effect of including the coverage required by subsection 1, and any provision of the policy or the renewal which is in conflict with this section is void.

4.

The provisions of this section do not require an insurer to provide coverage for fertility drugs.

5.

As used in this section, “provider of health care” has the meaning ascribed to it in NRS 629.031.

Source: Section 689A.0415 — Coverage for hormone replacement therapy in certain circumstances; prohibited actions by insurer; exception., https://www.­leg.­state.­nv.­us/NRS/NRS-689A.­html#NRS689ASec0415.

689A.040
Contents of policy 689A.041
Coverage relating to mastectomy. 689A.042
Coverage relating to complications of pregnancy. 689A.043
Coverage of newly born and adopted children and children placed for adoption. 689A.044
Required coverage for certain tests and vaccines relating to human papillomavirus 689A.046
Benefits for treatment of alcohol or substance use disorder. 689A.0403
Procedure for arbitration of disputes concerning independent medical, dental or chiropractic evaluations. 689A.0404
Coverage for use of certain drugs for treatment of cancer. 689A.0405
Coverage for mammograms for certain women 689A.0413
Coverage for certain gynecological or obstetrical services without authorization or referral from primary care physician. 689A.0415
Coverage for hormone replacement therapy in certain circumstances 689A.0417
Coverage for health care services related to hormone replacement therapy in certain circumstances 689A.0418
Coverage for drug or device for contraception and related health services 689A.0419
Coverage for certain services, screenings and tests relating to wellness 689A.0423
Coverage for treatment of certain inherited metabolic diseases. 689A.0424
Policy that includes coverage for maternity care must not deny coverage for gestational carrier 689A.0425
Individual health benefit plan that includes coverage for maternity care and pediatric care: Requirement to allow minimum stay in hospital in connection with childbirth 689A.0427
Coverage for management and treatment of diabetes. 689A.0428
Coverage for management and treatment of sickle cell disease. 689A.0435
Coverage for autism spectrum disorders. 689A.0445
Coverage for prostate cancer screening. 689A.0447
Coverage for orally administered chemotherapy. 689A.0455
Coverage for treatment of conditions relating to severe mental illness. 689A.0463
Coverage for services provided through telehealth 689A.0465
Coverage of treatment of temporomandibular joint. 689A.04033
Coverage for treatment received as part of clinical trial or study. 689A.04036
Coverage for continued medical treatment. 689A.04042
Coverage for screening for colorectal cancer. 689A.04045
Coverage for prescription drug previously approved for medical condition of insured. 689A.04046
Coverage for prescription drugs irregularly dispensed for purpose of synchronization of chronic medications. 689A.04047
Coverage for early refills of topical ophthalmic products.
Last Updated

Jun. 24, 2021

§ 689A.0415’s source at nv​.us